APA (7th ed.) Citation

Baird, M. C., Likhite, S. B., Vetter, T. A., Caporale, J. R., Girard, H. B., Roussel, F. S., . . . Meyer, K. C. (2024, September). Combination AAV therapy with galectin-1 and SOD1 downregulation demonstrates superior therapeutic effect in a severe ALS mouse model. Molecular Therapy: Methods & Clinical Development.

Chicago Style (17th ed.) Citation

Baird, Megan C., et al. "Combination AAV Therapy with Galectin-1 and SOD1 Downregulation Demonstrates Superior Therapeutic Effect in a Severe ALS Mouse Model." Molecular Therapy: Methods & Clinical Development Sep. 2024.

MLA (9th ed.) Citation

Baird, Megan C., et al. "Combination AAV Therapy with Galectin-1 and SOD1 Downregulation Demonstrates Superior Therapeutic Effect in a Severe ALS Mouse Model." Molecular Therapy: Methods & Clinical Development, Sep. 2024.